DDIT3 and breast cancer: Data revealed that AMP exposure time-dependently increased the expression of GRP78, p-PERK, p-elF2α, cleaved ATF6α, and CHOP in both breast cancer cell lines MCF-7 and MDA-MB-231 (Figure 4A).